Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
Cadila's ZyCov-D (DNA-based vaccine) is undergoing phase III trials.
With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints
The initiative will be led by David Baker, 2024 Nobel Prize winner in Chemistry, IPD director, professor of biochemistry, and HHMI Investigator at the University of Washington
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Biotium reports that GlycoLiner Labelling is fully covalent and compatible with standard fixation and permeabilization protocols
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
In light of the contributions of these three institutes, it was decided to organize a CSIR Startup Conclave in Hyderabad. The event, scheduled for April 22–23, 2025
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
Subscribe To Our Newsletter & Stay Updated
